Follow
Ana Maria Ortega Prieto
Ana Maria Ortega Prieto
Research Associate, Department of Infectious Diseases, King's College London
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
L Braga, H Ali, I Secco, E Chiavacci, G Neves, D Goldhill, R Penn, ...
Nature 594 (7861), 88-93, 2021
3422021
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
AM Ortega-Prieto, JK Skelton, SN Wai, E Large, M Lussignol, ...
Nature communications 9 (1), 682, 2018
2112018
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, ...
Nature microbiology 6 (11), 1433-1442, 2021
992021
Human organs-on-chips for virology
H Tang, Y Abouleila, L Si, AM Ortega-Prieto, CL Mummery, DE Ingber, ...
Trends in microbiology 28 (11), 934-946, 2020
992020
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis
AM Ortega-Prieto, J Sheldon, A Grande-Pérez, H Tejero, J Gregori, J Quer, ...
PloS one 8 (8), e71039, 2013
782013
T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses
CJ Reynolds, OM Suleyman, AM Ortega-Prieto, JK Skelton, ...
Scientific reports 8 (1), 672, 2018
642018
Immune evasion strategies during chronic hepatitis B and C virus infection
AM Ortega-Prieto, M Dorner
Vaccines 5 (3), 24, 2017
642017
A Hitchhiker's guide to humanized mice: new pathways to studying viral infections
JK Skelton, AM Ortega‐Prieto, M Dorner
Immunology 154 (1), 50-61, 2018
612018
Identification of broad-spectrum antiviral compounds by targeting viral entry
M Mazzon, AM Ortega-Prieto, D Imrie, C Luft, L Hess, S Czieso, J Grove, ...
Viruses 11 (2), 176, 2019
562019
An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era
A Pascual-Iglesias, J Canton, AM Ortega-Prieto, JM Jimenez-Guardeño, ...
Pathogens 10 (8), 1030, 2021
462021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
MJ Lista, PM Matos, TJA Maguire, K Poulton, E Ortiz-Zapater, R Page, ...
PLoS One 16 (9), e0256813, 2021
372021
In Vivo Model Systems for Hepatitis B Virus Research
AM Ortega-Prieto, C Cherry, H Gunn, M Dorner
ACS Infectious Diseases 5 (5), 688-702, 2018
362018
" liver-on-a-chip" cultures of primary hepatocytes and kupffer cells for hepatitis b virus infection
AM Ortega-Prieto, JK Skelton, C Cherry, MA Briones-Orta, CA Hateley, ...
MyJoVE Corporation, 2016
272016
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
LJ Pallett, L Swadling, M Diniz, AA Maini, M Schwabenland, AD Gasull, ...
Nature 614 (7947), 334-342, 2023
262023
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
PJ Liu, JM Harris, E Marchi, V D’arienzo, T Michler, PAC Wing, A Magri, ...
Scientific RepoRtS 10 (1), 14101, 2020
152020
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2
JM Jimenez-Guardeño, AM Ortega-Prieto, B Menendez Moreno, ...
PLoS computational biology 18 (7), e1010330, 2022
122022
Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection
AA Evripioti, AM Ortega-Prieto, JK Skelton, Q Bazot, M Dorner
Philosophical Transactions of the Royal Society B 374 (1773), 20180292, 2019
122019
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat Commun 9: 682
AM Ortega-Prieto, JK Skelton, SN Wai, E Large, M Lussignol, ...
122018
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B. 1.1. 7 infections
L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, SR Hallett, ...
MedRxiv, 2021
112021
Development of a structural epitope mimic: An idiotypic approach to HCV vaccine design
VM Cowton, AM Owsianka, V Fadda, AM Ortega-Prieto, SJ Cole, JA Potter, ...
npj Vaccines 6 (1), 1-10, 2021
102021
The system can't perform the operation now. Try again later.
Articles 1–20